GENERAL ONCOLOGY, INC.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Holding
- Established
- 2015-01-01
- Employees
- 1
- Market Cap
- -
SHARON: A Clinical Trial for Metastatic Cancer With a BRCA or PALB2 Mutation Using Chemotherapy and Patients' Own Stem Cells
Phase 1
Recruiting
- Conditions
- BRCA1 MutationPancreatic Acinar Cell CarcinomaBreast Cancer MetastaticBRCA2 MutationPancreatic CancerMetastatic Pancreatic Ductal AdenocarcinomaBreast Cancer Stage IVAdenocarcinoma of the BreastPancreatic Ductal AdenocarcinomaMetastatic Pancreatic Cancer
- Interventions
- Drug: Vitamin B12BDevice: Autologous Hematopoietic Stem Cells
- First Posted Date
- 2019-11-04
- Last Posted Date
- 2024-06-26
- Lead Sponsor
- General Oncology, Inc.
- Target Recruit Count
- 10
- Registration Number
- NCT04150042
- Locations
- 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States
🇺🇸Memorial Sloan Kettering Cancer Center, New York, New York, United States
© Copyright 2025. All Rights Reserved by MedPath